These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
323 related items for PubMed ID: 19553534
1. Zymosan, but not lipopolysaccharide, triggers severe and progressive peritoneal injury accompanied by complement activation in a rat peritonitis model. Mizuno M, Ito Y, Hepburn N, Mizuno T, Noda Y, Yuzawa Y, Harris CL, Morgan BP, Matsuo S. J Immunol; 2009 Jul 15; 183(2):1403-12. PubMed ID: 19553534 [Abstract] [Full Text] [Related]
2. Rat adipose tissue-derived stem cells attenuate peritoneal injuries in rat zymosan-induced peritonitis accompanied by complement activation. Kim H, Mizuno M, Furuhashi K, Katsuno T, Ozaki T, Yasuda K, Tsuboi N, Sato W, Suzuki Y, Matsuo S, Ito Y, Maruyama S. Cytotherapy; 2014 Mar 15; 16(3):357-68. PubMed ID: 24364907 [Abstract] [Full Text] [Related]
4. Anti-C5a complementary peptide mitigates zymosan-induced severe peritonitis with fibrotic encapsulation in rats pretreated with methylglyoxal. Iguchi D, Mizuno M, Suzuki Y, Sakata F, Maruyama S, Okada A, Okada H, Ito Y. Am J Physiol Renal Physiol; 2018 Dec 01; 315(6):F1732-F1746. PubMed ID: 30280601 [Abstract] [Full Text] [Related]
5. Acute inflammation in peritoneal dialysis: experimental studies in rats. Characterization of regulatory mechanisms. Bazargani F. Swed Dent J Suppl; 2005 Dec 01; (171):1-57, i. PubMed ID: 15847249 [Abstract] [Full Text] [Related]
6. C1 inhibitor mitigates peritoneal injury in zymosan-induced peritonitis. Ozeki T, Mizuno M, Iguchi D, Kojima H, Kim H, Suzuki Y, Kinashi H, Ishimoto T, Maruyama S, Ito Y. Am J Physiol Renal Physiol; 2021 Jun 01; 320(6):F1123-F1132. PubMed ID: 33818127 [Abstract] [Full Text] [Related]
7. Specific collaboration between rat membrane complement regulators Crry and CD59 protects peritoneum from damage by autologous complement activation. Mizuno T, Mizuno M, Morgan BP, Noda Y, Yamada K, Okada N, Yuzawa Y, Matsuo S, Ito Y. Nephrol Dial Transplant; 2011 Jun 01; 26(6):1821-30. PubMed ID: 21098015 [Abstract] [Full Text] [Related]
8. Complement terminal pathway inhibition reduces peritoneal injuries in a rat peritonitis model. Kamegai N, Kim H, Suzuki Y, Fukui S, Kojima H, Maruyama S, Morgan BP, Zelek WM, Mizuno M. Clin Exp Immunol; 2023 Dec 12; 214(2):209-218. PubMed ID: 37549240 [Abstract] [Full Text] [Related]
9. Atrial natriuretic peptide ameliorates peritoneal fibrosis in rat peritonitis model. Kato H, Mizuno T, Mizuno M, Sawai A, Suzuki Y, Kinashi H, Nagura F, Maruyama S, Noda Y, Yamada K, Matsuo S, Ito Y. Nephrol Dial Transplant; 2012 Feb 12; 27(2):526-36. PubMed ID: 21669883 [Abstract] [Full Text] [Related]
10. Role of rosiglitazone in lipopolysaccharide-induced peritonitis: a rat peritoneal dialysis model. Song SH, Kwak IS, Yang BY, Lee DW, Lee SB, Lee MY. Nephrology (Carlton); 2009 Apr 12; 14(2):155-63. PubMed ID: 19207869 [Abstract] [Full Text] [Related]
11. Anti-C5a complementary peptide ameliorates acute peritoneal injury induced by neutralization of Crry and CD59. Mizuno T, Mizuno M, Imai M, Suzuki Y, Kushida M, Noda Y, Maruyama S, Okada H, Okada N, Matsuo S, Ito Y. Am J Physiol Renal Physiol; 2013 Dec 01; 305(11):F1603-16. PubMed ID: 23904221 [Abstract] [Full Text] [Related]
12. Chapter 17. Zymosan-induced peritonitis as a simple experimental system for the study of inflammation. Cash JL, White GE, Greaves DR. Methods Enzymol; 2009 Dec 01; 461():379-96. PubMed ID: 19480928 [Abstract] [Full Text] [Related]
13. Spontaneous peritonitis and peritoneal fibrosis in rats on peritoneal dialysis for 9 weeks. Suzuki K, Khanna R, Nolph KD, Moore HL, Twardowski ZJ. Adv Perit Dial; 1995 Dec 01; 11():52-6. PubMed ID: 8534737 [Abstract] [Full Text] [Related]
14. Mast cell-expressed complement receptor, not TLR2, is the main detector of zymosan in peritonitis. Mullaly SC, Kubes P. Eur J Immunol; 2007 Jan 01; 37(1):224-34. PubMed ID: 17154261 [Abstract] [Full Text] [Related]
15. Acute peritonitis in a C57BL/6 mouse model of peritoneal dialysis. Leypoldt JK, Kamerath CD, Gilson JF. Adv Perit Dial; 2007 Jan 01; 23():66-70. PubMed ID: 17886606 [Abstract] [Full Text] [Related]
16. Resistance to experimental peritonitis induced by local nonspecific stimulation of the reticuloendothelial system. Joyce LD, Mauer HG, Smith JM, Lillehei RC. Adv Shock Res; 1980 Jan 01; 4():49-54. PubMed ID: 7315620 [Abstract] [Full Text] [Related]
17. The effects of oral Cardax (disodium disuccinate astaxanthin) on multiple independent oxidative stress markers in a mouse peritoneal inflammation model: influence on 5-lipoxygenase in vitro and in vivo. Lockwood SF, Penn MS, Hazen SL, Bikádi Z, Zsila F. Life Sci; 2006 Jun 06; 79(2):162-74. PubMed ID: 16466747 [Abstract] [Full Text] [Related]
18. Zymosan induces nitric oxide production by peritoneal mesothelial cells. Yao V, McCauley R, Cooper D, Platell C, Hall JC. ANZ J Surg; 2004 Apr 06; 74(4):266-9. PubMed ID: 15043739 [Abstract] [Full Text] [Related]
19. Impaired TGF-beta signalling enhances peritoneal inflammation induced by E. coli in rats. Wang X, Nie J, Jia Z, Feng M, Zheng Z, Chen W, Li X, Peng W, Zhang S, Sun L, Mao H, Lan HY, Yu X. Nephrol Dial Transplant; 2010 Feb 06; 25(2):399-412. PubMed ID: 19759272 [Abstract] [Full Text] [Related]
20. Pyridoxal phosphate and hepatocyte growth factor prevent dialysate-induced peritoneal damage. Nakamura S, Niwa T. J Am Soc Nephrol; 2005 Jan 06; 16(1):144-50. PubMed ID: 15563557 [Abstract] [Full Text] [Related] Page: [Next] [New Search]